Citichem India IPO Details

Fixed Price IPO | ₹13 Cr | Listed at BSE SME | Fri, Dec 27, 2024 - Tue, Dec 31, 2024

Citichem India IPO Logo

Citichem India IPO is a fixed price issue of ₹12.60 crores. The issue is entirely a fresh issue of 0.18 crore shares of ₹12.60 crore.

Citichem India IPO bidding started from Dec 27, 2024 and ended on Dec 31, 2024. The allotment for Citichem India IPO was finalized on Jan 1, 2025. The shares got listed on BSE SME on Jan 3, 2025.

Citichem India IPO price is ₹70 per share. The lot size for an application is 2,000. The minimum amount of investment required by an individual investor (retail) is ₹1,40,000 (2000 shares) (based on upper price). The minimum lot size for investment in HNI is 2 lots (4,000 shares), amounting to ₹2,80,000.

Horizon Management Pvt.Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue. The Market Maker of the company is Aftertrade Broking Pvt.Ltd..

Refer to Citichem India IPO RHP for detailed Information.

IPO Open

Fri, Dec 27, 2024

IPO Close

Tue, Dec 31, 2024

Issue Price

₹70 per share

Market Cap (Pre-IPO)

₹47.60 Cr

IPO Details

IPO Date27 to 31 Dec, 2024
Listed onFri, Jan 3, 2025
Face Value10 per share
Issue Price₹70 per share
Lot Size2,000 Shares
Sale TypeFresh capital only
Issue TypeFixed Price IPO
Listing AtBSE SME

Total Issue Size18,00,000 shares
(agg. up to ₹13 Cr)
Reserved for Market Maker
92,000 shares
(agg. up to ₹0.6440 Cr)
Aftertrade Broking Pvt.Ltd.
Fresh Issue
(Ex Market Maker)
17,08,000 shares
(agg. up to ₹12 Cr)
Net Offered to Public17,08,000 shares
(agg. up to ₹12 Cr)
Share Holding Pre Issue50,00,000 shares
Share Holding Post Issue68,00,000 shares
BSE Script Code 544324
ISININE0A8401016

IPO Timetable

Issue Reservation

Citichem India IPO comprises a total issue size of 18,00,000 shares. The net offer to the public is 17,08,000 shares, after excluding 92,000 shares allotted on a firm basis. Of the Net offer 8,54,000 (50.00%) allocated to NII 8,54,000 (50.00%) allocated to RII.

Investor Category Shares Offered % of Net Issue% of Total Issue
NII (HNI) Shares Offered 8,54,00050.00%47.44%
Retail Shares Offered 8,54,00050.00%47.44%
Firm Reservations
Market Maker Shares Offered 92,0005.11%
Total Shares Offered 18,00,000100.00%100.00%

IPO Lot Size

Investors can bid for a minimum of 2,000 shares and in multiples thereof. 

Application Lots Shares Amount
Retail (Min) 1 2,000 ₹1,40,000
Retail (Max) 1 2,000 ₹1,40,000
HNI (Min) 2 4,000 ₹2,80,000
IPO Subscription Details

About Citichem India Ltd.

Incorporated in 1992, Citichem India Limited is engaged in buying and supplying organic and inorganic chemicals, bulk drugs, and food chemicals to the the pharmaceutical industry.

The company focuses on the direct supply of specialty chemicals, bulk drugs, and intermediate products.

It trades in specialty chemicals and intermediates that have a wide range of applications across industries such as aluminum, steel, textiles, paper, dairy, paints, dyes and intermediates, soap making, pharmaceuticals, food, and adhesives.

The company also supplies food preservatives and chemicals under its brand name, which are then sold through its distribution team, ensuring the safe delivery of bulk supplies.

The company supplies products such as Caustic Soda Flakes, Caustic Soda Lye, Citric Acid Monohydrate, Hydrogen Peroxide, and more.

Business division:

  • Specialty Chemicals, Intermediates & Active Pharmaceutical Ingredients (API): The company specializes in indenting, sourcing, make-to-order outsourcing, and supplying specialty chemicals, bulk drugs, and APIs to domestic and international clients in the pharmaceutical, paint, and food industries.
  • Food Chemicals: The company handles the repackaging, retail distribution, and marketing of food chemicals.
  • Laboratory Chemicals: The company offers a one-stop solution for all types of laboratory chemicals.

As of June 30, 2024, The company has 9 employees.

Competitive Strengths:

  • Experienced Promoters and management team
  • Scalable Business Model
  • Focus on quality and innovation
  • Location Advantage
  • Cordial Relationships with Suppliers &Customers
  • Dedicated after-sales network

Company Financials (Restated)

Period Ended30 Jun 202431 Mar 202431 Mar 202331 Mar 2022
Assets68.5269.3379.7391.43
Total Income1.4919.6120.9485.28
Profit After Tax0.201.120.360.24
NET Worth7.457.256.135.77
Reserves and Surplus2.452.251.130.77
Total Borrowing1.081.081.101.11
Amount in ₹ Crore

IPO Objects of the Issue

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:

# Issue Objects Est Amt (₹ Cr.)
1 For Capital expenditure for acquisition of Property; 3.60
2 For purchasing of Transportation Vehicles and accessories; 4.69
3 For General Corporate Purposes; 2.80

Key Performance Indicator (KPI)

KPIMar 31, 2024
ROE15.42%
ROCE21.47%
Debt/Equity0.15
RoNW15.42%
PAT Margin5.70%
Pre IPOPost IPO
EPS (₹)2.241.17
P/E (x)31.359.65
Promoter Holding83.25%61.21%
Market Cap47.60 Cr.
Mr. Arif Esmail Merchant, Mr. Hashim Arif Merchant, Mrs. Fozia Arif Esmail Merchant and Mrs. Saima Hashim Merhant are the promoters of the company.
  • The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
  • The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latest FY earnings as of March 31, 2024 available in RHP.
  • The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of June 30, 2024 available in RHP.

IPO Review

[Dilip Davda]
The company is mainly engaged in supplying third party products in organic/inorganic chemicals, bulk drugs, food chemicals, Pharmaceuticals, etc. It marked drastic de-growth in its top lines for the reported periods, but net margin surged from FY24 onwards that raise eyebrows and concern over its sustainability going forward as it is operating in a highly competitive and fragmented segment. Higher spending for IPO process hints at structured and managed funding. Small equity base post-IPO indicates longer gestation for migration. Based on its recent super earnings, the issue appears aggressively priced. There is no harm in skipping this “High Risk/Low Return” bet.
Read detail review...

Citichem India IPO Recommendations

Review BySubscribeMay ApplyNeutralAvoid
Brokers0001
Members0000

Citichem India IPO Subscription Status (Bidding Detail)

The Citichem India IPO is subscribed 414.35 times on December 31, 2024 6:19:08 PM (Day 3). The public issue subscribed 543.18 times in the retail category, [.] times in the QIB category, and 277.88 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategorySubscription (times)Shares OfferedShares bid forTotal Application
NII*277.888,54,00023,73,06,00023,162
Retail543.188,54,00046,38,72,0002,31,936
Total414.3517,08,00170,77,06,0003,06,306

Total Application : 3,06,306

*Market Maker portion is not included to NII/HNI.

IPO Expenses

# Issue Expenses Est Amt (₹ Cr.)
1 Issue Management fees including fees and reimbursements of Market Making fees, underwriting fees, selling fees and payment to other intermediaries such as Legal Advisors, Advisor to the company, Registrar to the Issue and other out of pocket expenses 1.28
2 Fees payable to advertising and marketing expense 0.09
3 Fees Payable to regulators including stock exchange 0.04
4 Printing and stationery expenses 0.01
5 Brokerage and Selling Commission 0.09

Listing Day Trading Information

Price DetailsBSE SME
Final Issue Price70.00
Open70.00
Low66.50
High70.00
Last Trade68.28

Check IPO Performance…

IPO Registrar

Kfin Technologies Ltd.

  • 04067162222, 04079611000
  • citichemindia.ipo@kfintech.com
  • Visit Website

Contact Details

Citichem India Ltd. Address
7, Floor-1, Plot-96,
Dharam Jyoti, Kazi Sayed Street, Khand Bazar,
Masjid Station, Mandvi
Mumbai, Maharashtra, 400003
Open an Instant Account with Zerodha

IPO FAQs

Citichem India IPO is a SME IPO of 18,00,000 equity shares of the face value of ₹10 aggregating up to ₹13 Crores. The issue is priced at ₹70 per share. The minimum order quantity is 2000.

The IPO opens on Fri, Dec 27, 2024, and closes on Tue, Dec 31, 2024.

Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.

Zerodha customers can apply online in Citichem India IPO using UPI as a payment gateway. Zerodha customers can apply in Citichem India IPO by login into Zerodha Console (back office) and submitting an IPO application form.

Steps to apply in Citichem India IPO through Zerodha

  1. Visit the Zerodha website and login to Console.
  2. Go to Portfolio and click the IPOs link.
  3. Go to the 'Citichem India IPO' row and click the 'Bid' button.
  4. Enter your UPI ID, Quantity, and Price.
  5. Submit IPO application form.
  6. Visit the UPI App (net banking or BHIM) to approve the mandate.

Visit Zerodha IPO Application Process Review for more detail.

The Citichem India IPO opens on Fri, Dec 27, 2024 and closes on Tue, Dec 31, 2024.

Citichem India IPO lot size is 2000, and the minimum amount required for application is ₹1,40,000.

You can apply in Citichem India IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.

The finalization of Basis of Allotment for Citichem India IPO will be done on Wednesday, January 1, 2025, and the allotted shares will be credited to your demat account by Thu, Jan 2, 2025. Check the Citichem India IPO allotment status.

The Citichem India IPO listing date is on Fri, Jan 3, 2025.

Compare: